Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v2.4.0.8
Condensed Consolidated Balance Sheets (USD $)
Jun. 30, 2013
Dec. 31, 2012
Current Assets    
Cash and cash equivalents $ 586,016 $ 2,197,555
Marketable securities 1,085,039 1,598,209
Restricted cash 554,452 553,682
Accounts receivable - project revenue and reimbursable project costs 663,229 601,803
Prepaid expenses & other current assets 521,745 574,590
Total Current Assets 3,410,481 5,525,839
Property Plant and Equipment -net 4,831 17,221
Other Assets    
Patent costs - net 673,950 600,596
Total Assets 4,089,262 6,143,656
Current Liabilities    
Accounts payable and accrued liabilities 422,942 385,223
Total Current Liabilities 422,942 385,223
Stockholders' Equity    
Preferred stock, $0.001 par value, 50,000,000 authorized shares, no shares issued and outstanding 0 0
Common stock, $0.001 par value, 500,000,000 authorized, 12,556,400 shares and 12,526,240 shares outstanding at June 30, 2013 and December 31, 2012, respectively 12,556 12,526
Additional paid in capital - stock and stock equivalents 72,169,379 71,955,631
Deficit (68,515,615) (66,212,849)
Common stock reserved for issuance, 2,264 shares at December 31, 2012 0 3,125
Total Stockholders' Equity 3,666,320 5,758,433
Total Liabilities and Stockholders' Equity $ 4,089,262 $ 6,143,656